- Home
- AYTU vs HTOO Comparison
AYTU vs HTOO Comparison
Compare AYTU & HTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- HTOO
- Stock Information
- Founded
- AYTU N/A
- HTOO 2020
- Country
- AYTU United States
- HTOO Ireland
- Employees
- AYTU N/A
- HTOO N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- HTOO Natural Gas Distribution
- Sector
- AYTU Health Care
- HTOO Utilities
- Exchange
- AYTU Nasdaq
- HTOO Nasdaq
- Market Cap
- AYTU 15.0M
- HTOO 12.3M
- IPO Year
- AYTU N/A
- HTOO N/A
- Fundamental
- Price
- AYTU $2.21
- HTOO $0.54
- Analyst Decision
- AYTU
- HTOO Buy
- Analyst Count
- AYTU 0
- HTOO 2
- Target Price
- AYTU N/A
- HTOO $3.25
- AVG Volume (30 Days)
- AYTU 30.7K
- HTOO 162.1K
- Earning Date
- AYTU 11-12-2024
- HTOO 12-02-2024
- Dividend Yield
- AYTU N/A
- HTOO N/A
- EPS Growth
- AYTU N/A
- HTOO N/A
- EPS
- AYTU N/A
- HTOO N/A
- Revenue
- AYTU $81,002,000.00
- HTOO $4,580,524.00
- Revenue This Year
- AYTU N/A
- HTOO $440.97
- Revenue Next Year
- AYTU N/A
- HTOO $214.20
- P/E Ratio
- AYTU N/A
- HTOO N/A
- Revenue Growth
- AYTU N/A
- HTOO N/A
- 52 Week Low
- AYTU $2.20
- HTOO $0.46
- 52 Week High
- AYTU $3.50
- HTOO $4.65
- Technical
- Relative Strength Index (RSI)
- AYTU 39.00
- HTOO 44.88
- Support Level
- AYTU $2.26
- HTOO $0.50
- Resistance Level
- AYTU $2.44
- HTOO $0.56
- Average True Range (ATR)
- AYTU 0.14
- HTOO 0.05
- MACD
- AYTU -0.02
- HTOO 0.01
- Stochastic Oscillator
- AYTU 2.03
- HTOO 64.35
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.
About HTOO Fusion Fuel Green PLC
Fusion Fuel Green PLC is a company that has developed a Green Hydrogen production technology. It is focused on generating cost-effective and competitively priced Green Hydrogen.